BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14559152)

  • 21. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease.
    Song P; Li S; Wu H; Gao R; Rao G; Wang D; Chen Z; Ma B; Wang H; Sui N; Deng H; Zhang Z; Tang T; Tan Z; Han Z; Lu T; Zhu Y; Chen Q
    Protein Cell; 2016 Feb; 7(2):114-29. PubMed ID: 26746706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How does parkin ligate ubiquitin to Parkinson's disease?
    Kahle PJ; Haass C
    EMBO Rep; 2004 Jul; 5(7):681-5. PubMed ID: 15229644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
    Corti O; Hampe C; Koutnikova H; Darios F; Jacquier S; Prigent A; Robinson JC; Pradier L; Ruberg M; Mirande M; Hirsch E; Rooney T; Fournier A; Brice A
    Hum Mol Genet; 2003 Jun; 12(12):1427-37. PubMed ID: 12783850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.
    Ren Y; Zhao J; Feng J
    J Neurosci; 2003 Apr; 23(8):3316-24. PubMed ID: 12716939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease.
    Fukae J; Sato S; Shiba K; Sato K; Mori H; Sharp PA; Mizuno Y; Hattori N
    FEBS Lett; 2009 Feb; 583(3):521-5. PubMed ID: 19146857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?
    Lim KL; Dawson VL; Dawson TM
    Neurobiol Aging; 2006 Apr; 27(4):524-9. PubMed ID: 16213628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
    Im E; Chung KC
    J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkin: much more than a simple ubiquitin ligase.
    Alves da Costa C; Checler F
    Neurodegener Dis; 2012; 10(1-4):49-51. PubMed ID: 22204976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neddylation positively regulates the ubiquitin E3 ligase activity of parkin.
    Um JW; Han KA; Im E; Oh Y; Lee K; Chung KC
    J Neurosci Res; 2012 May; 90(5):1030-42. PubMed ID: 22271254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.
    Im E; Yoo L; Hyun M; Shin WH; Chung KC
    Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
    Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
    Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkin and endoplasmic reticulum stress.
    Takahashi R; Imai Y; Hattori N; Mizuno Y
    Ann N Y Acad Sci; 2003 Jun; 991():101-6. PubMed ID: 12846978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease.
    Korutla L; Furlong HA; Mackler SA
    Neuroscience; 2014 Jan; 257():86-95. PubMed ID: 24231739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pael-R is accumulated in Lewy bodies of Parkinson's disease.
    Murakami T; Shoji M; Imai Y; Inoue H; Kawarabayashi T; Matsubara E; Harigaya Y; Sasaki A; Takahashi R; Abe K
    Ann Neurol; 2004 Mar; 55(3):439-42. PubMed ID: 14991825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational Impact on "in-Between-Ring" (IBR) Domain of PARKIN on Protein Stability and Function.
    Biswas S; Bagchi A
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1603-1616. PubMed ID: 33471285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10.
    Bertolin G; Jacoupy M; Traver S; Ferrando-Miguel R; Saint Georges T; Grenier K; Ardila-Osorio H; Muriel MP; Takahashi H; Lees AJ; Gautier C; Guedin D; Coge F; Fon EA; Brice A; Corti O
    Cell Death Differ; 2015 Oct; 22(10):1563-76. PubMed ID: 25591737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
    Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
    Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.